Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash from Investing Activities (2016 - 2025)

Bio-Techne has reported Cash from Investing Activities over the past 17 years, most recently at -$5.9 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$5.9 million for Q4 2025, down 17.67% from a year ago — trailing twelve months through Dec 2025 was -$13.8 million (up 73.48% YoY), and the annual figure for FY2025 was -$35.2 million, up 82.67%.
  • Cash from Investing Activities for Q4 2025 was -$5.9 million at Bio-Techne, down from $605000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for TECH hit a ceiling of $605000.0 in Q3 2025 and a floor of -$241.1 million in Q1 2023.
  • Median Cash from Investing Activities over the past 5 years was -$12.7 million (2024), compared with a mean of -$41.6 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 28001.55% in 2022 and later surged 104.61% in 2025.
  • Bio-Techne's Cash from Investing Activities stood at -$35.2 million in 2021, then soared by 99.69% to -$109000.0 in 2022, then tumbled by 21616.51% to -$23.7 million in 2023, then soared by 78.74% to -$5.0 million in 2024, then dropped by 17.67% to -$5.9 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$5.9 million (Q4 2025), $605000.0 (Q3 2025), and $406000.0 (Q2 2025) per Business Quant data.